نتایج جستجو برای: شرکت merck

تعداد نتایج: 54045  

Journal: :Journal of Synthetic Organic Chemistry, Japan 2007

Journal: :Proceedings of the American Philosophical Society 2001
P R Vagelos

HE PHARMACEUTICAL INDUSTRY has as its objective the discovery of important new medicines and vaccines to prevent and alleviate diseases and to improve health and the quality of life. Merck has been doing that successfully since 1933, when George W. Merck opened the first laboratory in Rahway, New Jersey. Through the efforts of its research scientists, the company has contributed drugs and vacci...

2016
Simon Travis Geert R. D’Haens Julián Panés Stefan Schreiber

Disclosure: Prof Simon Travis has been an advisor to, in receipt of educational or research grants from, or an invited lecturer for AbbVie, Amgen, Asahi, Biogen, Boehringer Ingelheim, BMS, Cosmo, Elan, Ferring, FPRT Bio, Genentech/Roche, Genzyme, Glenmark, GW Pharmaceuticals, Lilly, Merck, Novartis, Novo Nordisk, Ocera, Pfizer, Receptos, Shire, Santarus, SigmoidPharma, Synthon, Takeda, Tillotts...

Journal: :Decision Support Systems 2006
Gholamreza Torkzadeh Jerry Cha-Jan Chang Gregory W. Hansen

This paper reports the results of a study designed in close collaboration with Merck-Medco to identify key barriers to the success of their customer relationship management. To identify the key factors, we first used focus groups of principle users of the system to brainstorm and generate a list of scenarios and issues. A team of managers, supervisors and customer service representatives then c...

2001
Franco Malerba Luigi Orsenigo

We thank Luca Berga, Christian Garavaglia and Nicola Lacetera for their invaluable contribution to the development of the model. We thank the Merck Foundation for its support through the Epris (European Pharmaceutical Regulation and Innovation Systems) Project. 2

Journal: :Diabetes 2001
M Li J F Youngren V P Manchem M Kozlowski B B Zhang B A Maddux I D Goldfine

In type 2 diabetes, impaired insulin signaling leads to hyperglycemia and other metabolic abnormalities. To study a new class of antidiabetic agents, we compared two small, nonpeptide molecules that activate insulin receptor (IR) beta-subunit tyrosine kinase activity: Merck L7, a direct IR agonist, and Telik's TLK16998, an IR sensitizer. In rat hepatoma cells (HTCs) that overexpress the IR (HTC...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید